Drug Panel Asks Protection For Volunteers

LONDON—The U.K. Medicines Commission is calling for a clampdown on independent contractors who hire healthy volunteers to test experimental drugs, but the code may never be enacted. The drug regulation agency, headed by Rosalinde Hurley of London University, wants a register of contractors, limits on payments to experimental subjects, and guarantees that the volunteers will get full medical backup and nofault compensation if they suffer side effects. Its proposal is prompted by concern

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON—The U.K. Medicines Commission is calling for a clampdown on independent contractors who hire healthy volunteers to test experimental drugs, but the code may never be enacted.

The drug regulation agency, headed by Rosalinde Hurley of London University, wants a register of contractors, limits on payments to experimental subjects, and guarantees that the volunteers will get full medical backup and nofault compensation if they suffer side effects. Its proposal is prompted by concern over the increasing numbers of independent contractors setting up shop to test experimental drugs for pharmaceutical companies.

Ministers asked the commission three years ago to produce safeguards following an outcry over the death of two student volunteers.

Hurley’s team produced its report one year ago. Ministers delayed publication until September, and no substantial government reply is expected until early next year.

More than 8,000 people volunteer for Phase 1 trials of potential new products every year in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Andrew Veitch

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo